Gonadal toxicity of Hodgkin lymphoma treatment in adolescents and young males: issue relevance and ways of solve (literature review)

Cover Page

Cite item

Full Text

Abstract

Hodgkin`s Lymphoma (HL) is one of the most curable cancer disease. A half of all patients are young males under 35 years old. Gonadal toxicity is one of the most frequent late effects of HL therapy and associated with significant decrease in patient’s quality of life. In present article frequency and risk factors of gonadal toxicity in males with HL were summarized. It was shown that chemotherapy with alkylating agents and radiotherapy may lead to gonadal toxicity in significant number of patients. Current possibilities of semen cryopreservation before start of the treatment are discussed.

About the authors

A. A. Vinokurov

Federal Research Center of Pediatric Hematology, Oncology and Immunology

Author for correspondence.
Email: a_vinokurov@inbox.ru
Russian Federation

S. R. Varfolomeeva

Federal Research Center of Pediatric Hematology, Oncology and Immunology

Russian Federation

D. I. Tarusin

Scientific and Practical Center of Children and Adolescents Andrology Moscow Department of Public Health

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.